Research Article
[Retracted] Correlation between LRP1B Mutations and Tumor Mutation Burden in Gastric Cancer
Table 1
Relationship between LRP1B gene mutation status and clinical characteristics in patients with gastric cancer.
| | LRP1B MUT () | LRP1B WT () | value |
| Gender | | | | Female | 36 (32.1%) | 104 (40.0%) | 0.187 | Male | 76 (67.9%) | 156 (60.0%) | | Age (years) | | | | | 25 (22.3%) | 91 (35.0%) | 0.021 | | 87 (77.7%) | 169 (65.0%) | | Event | | | | Yes | 39 (34.8%) | 90 (34.6%) | 1 | No | 73 (65.2%) | 170 (65.4%) | | Grade | | | | G1 | 1 (0.9%) | 7 (2.7%) | 0.462 | G2 | 36 (32.1%) | 90 (34.6%) | | G3 | 75 (67.0%) | 163 (62.7%) | | Stage | | | | Stage I | 14 (12.5%) | 31 (11.9%) | 0.883 | Stage II | 34 (30.4%) | 86 (33.1%) | | Stage III | 50 (44.6%) | 117 (45.0%) | | Stage IV | 14 (12.5%) | 26 (10.0%) | | T | | | | T1 | 7 (6.2%) | 10 (3.8%) | 0.389 | T2 | 17 (15.2%) | 56 (21.5%) | | T3 | 54 (48.2%) | 125 (48.1%) | | T4 | 34 (30.4%) | 69 (26.5%) | | N | | | | N0 | 39 (34.8%) | 78 (30.0%) | 0.565 | N1 | 26 (23.2%) | 73 (28.1%) | | N2 | 21 (18.8%) | 57 (21.9%) | | N3 | 26 (23.2%) | 52 (20.0%) | | M | | | | M0 | 103 (92.0%) | 242 (93.1%) | 0.872 | M1 | 9 (8.0%) | 18 (6.9%) | | KRAS | | | | Mut | 10 (8.9%) | 22 (8.5%) | 1 | Wild | 102 (91.1%) | 238 (91.5%) | | TP53 | | | | Mut | 62 (55.4%) | 112 (43.1%) | 0.039 | Wild | 50 (44.6%) | 148 (56.9%) | | MUC16 | | | | Mut | 67 (59.8%) | 73 (28.1%) | <0.001 | Wild | 45 (40.2%) | 187 (71.9%) | |
|
|